---
title: High success rate of first proficiency testing for RET fusions and RET mutations
  in lung and thyroid cancer samples by various methods
date: '2024-08-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39120655/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240809181323&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: This study describes the external quality assessment (EQA) scheme for
  molecular testing of RET alterations in non-small cell lung cancer (NSCLC), medullary
  thyroid carcinomas (MTC), and non-MTC. The lead panel institute and Quality Assurance
  Initiative in Pathology (Qualitätssicherungs-Initiative Pathologie [QuIP] GmbH)
  selected formalin-fixed paraffin-embedded (FFPE) tissue from MTC for RET mutation
  testing by next-generation sequencing (NGS) methods and FFPE tissue from NSCLC and
  non-MTC ...
disable_comments: true
---
This study describes the external quality assessment (EQA) scheme for molecular testing of RET alterations in non-small cell lung cancer (NSCLC), medullary thyroid carcinomas (MTC), and non-MTC. The lead panel institute and Quality Assurance Initiative in Pathology (Qualitätssicherungs-Initiative Pathologie [QuIP] GmbH) selected formalin-fixed paraffin-embedded (FFPE) tissue from MTC for RET mutation testing by next-generation sequencing (NGS) methods and FFPE tissue from NSCLC and non-MTC ...